A prospective multicenter study assessing the long-term effectiveness of Ustekinumab in patients with active Crohn's disease
Latest Information Update: 26 Apr 2022
At a glance
- Drugs Ustekinumab (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
Most Recent Events
- 26 Apr 2022 New trial record
- 22 Apr 2022 Results published in the Digestive Diseases and Sciences